INT MEDICAL (01501) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express
03/17

Shanghai INT Medical Instruments Co., Ltd. (INT MEDICAL, 01501) will convene a board meeting on 27 March 2026 in Shanghai. According to the company’s announcement, directors will review and approve the audited annual results of INT MEDICAL and its subsidiaries for the financial year ended 31 December 2025. The agenda also includes the potential declaration of a final dividend.

The notice was signed by Chairman Dr. Liang Dongke and dated 17 March 2026. The board currently consists of two executive directors, four non-executive directors and three independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10